3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
5
Lung Neoplasms
5
Breast Neoplasms
4
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Hepatocellular
3
Stomach Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Lymphatic Metastasis
2
Head and Neck Neoplasms
2
Esophageal Neoplasms
2
Breast Cancer Lymphedema
2
Brain Neoplasms
2
Vulvar Neoplasms
1
Uterine Neoplasms
1
Solid Tumor
1
Sarcoma, Ewing
1
Right Hemicolectomy
1
Rhabdomyosarcoma
1
Parathyroid Diseases
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neuroblastoma
1
Mixed Tumor, Mesodermal
1
Mesothelioma, Malignant
1
Melanoma
1
Margins of Excision
1
Lymphoma
1
Inflammatory Breast Neoplasms
1
Giant Cell Tumor of Tendon Sheath
1
Interventions
pembrolizumab
16
Nivolumab
15
Ipilimumab
12
cemiplimab
10
aldesleukin
6
Interleukin-2
6
Cyclophosphamide
6
fludarabine
5
fludarabine phosphate
4
encorafenib
4
binimetinib
4
Blood Specimen Collection
4
avelumab
3
Sirolimus
3
trametinib
2
spartalizumab
2
lifileucel
2
dabrafenib
2
atezolizumab
2
Vemurafenib
2
Surgical Procedures, Operative
2
Specimen Handling
2
Radiotherapy
2
Prednisone
2
Niacinamide
2
Exercise
2
Everolimus
2
Dermoscopy
2
Biopsy
2
urelumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Skin Neoplasms
×
Indocyanine Green
×
1 year
×
Clear all
No trials found.